Guardian Pharmacy Services, Inc.
GRDNUnited States
18 filed reports · 224 financial concepts · 4 earnings calls · 0 media appearances
Filed reports
18 reports · Sep 2024 to Jun 2026Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 20 guidance figures.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Current · 8-KSEC EDGAR | 10 | 20 | Sep 2024 to Jun 2026 |
| Quarterly · 10-QSEC EDGAR | 6 | 735 | Sep 2024 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 2 | 865 | Dec 2024 to Dec 2025 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q2 | 10-Q | Jun 30, 2026 | Aug 6, 2026 | 210 | Open |
| FY2026 Q2 | 8-K | Jun 30, 2026 | Aug 6, 2026 | 2 | Open |
| FY2026 Q1 | 10-Q | Mar 31, 2026 | May 6, 2026 | 132 | Open |
| FY2026 Q1 | 8-K | Mar 31, 2026 | May 6, 2026 | 2 | Open |
| FY2025 | 10-K | Dec 31, 2025 | Mar 11, 2026 | 553 | Open |
| FY2025 Q4 | 8-K | Dec 31, 2025 | Mar 11, 2026 | 2 | Open |
| FY2025 Q4 | 8-K | Dec 31, 2025 | Jan 13, 2026 | 2 | Open |
| FY2025 Q3 | 10-Q | Sep 30, 2025 | Nov 10, 2025 | 159 | Open |
| FY2025 Q3 | 8-K | Sep 30, 2025 | Nov 10, 2025 | 2 | Open |
| FY2025 Q2 | 10-Q | Jun 30, 2025 | Aug 11, 2025 | 82 | Open |
| FY2025 Q2 | 8-K | Jun 30, 2025 | Aug 11, 2025 | 2 | Open |
| FY2025 Q1 | 10-Q | Mar 31, 2025 | May 12, 2025 | 83 | Open |
Financial data
224 concepts · 1,620 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial214 concepts · 1,483 facts · Mar 2023 to Jun 2026
- Non-Controlling Interests17 · Mar 2023 to Jun 2026
- Stockholders equity including portion attributable to noncontrolling interest17 · Mar 2023 to Jun 2026
- Cash cash equivalents restricted cash and restricted cash equivalents15 · Sep 2023 to Jun 2026
- Cost of goods and services sold (US GAAP)15 · Sep 2023 to Jun 2026
- Gross profit (US GAAP)15 · Sep 2023 to Jun 2026
- Interest expense nonoperating15 · Sep 2023 to Jun 2026
- Legal fees15 · Sep 2023 to Jun 2026
- Net income loss attributable to noncontrolling interest15 · Sep 2023 to Jun 2026
- Nonoperating income expense15 · Sep 2023 to Jun 2026
- Operating income loss15 · Sep 2023 to Jun 2026
- Other nonoperating income expense15 · Sep 2023 to Jun 2026
- Profit loss15 · Sep 2023 to Jun 2026
- Revenue15 · Sep 2023 to Jun 2026
- Selling general and administrative expense15 · Sep 2023 to Jun 2026
- Cash cash equivalents restricted cash and restricted cash equivalents period increase decrease including exchange rate effect14 · Dec 2023 to Jun 2026
- Depreciation depletion and amortization14 · Dec 2023 to Jun 2026
- Finance lease principal payments14 · Dec 2023 to Jun 2026
- Increase decrease in accounts payable14 · Dec 2023 to Jun 2026
- Increase decrease in accounts receivable14 · Dec 2023 to Jun 2026
- Increase decrease in employee related liabilities14 · Dec 2023 to Jun 2026
- Increase decrease in inventories14 · Dec 2023 to Jun 2026
- Increase decrease in other current assets14 · Dec 2023 to Jun 2026
- Increase decrease in other operating liabilities14 · Dec 2023 to Jun 2026
- Interest paid net14 · Dec 2023 to Jun 2026
Segment9 concepts · 117 facts · Dec 2023 to Jun 2026
- Allocated share based compensation expense13 · Dec 2023 to Jun 2026
- Corporate Segment13 · Dec 2023 to Jun 2026
- Depreciation depletion and amortization13 · Dec 2023 to Jun 2026
- Income tax expense benefit13 · Dec 2023 to Jun 2026
- Interest expense operating13 · Dec 2023 to Jun 2026
- Net income loss13 · Dec 2023 to Jun 2026
- Profit loss13 · Dec 2023 to Jun 2026
- Revenue13 · Dec 2023 to Jun 2026
- Segment reporting other item amount13 · Dec 2023 to Jun 2026
Guidance1 concepts · 20 facts · Nov 2024 to Aug 2026
- Revenue Guidance20 · Nov 2024 to Aug 2026
Segments
117 factsFigures broken down by business line, region, product or another axis the company reports on.
Statement business segments1 member · 117 facts
- Corporate117 · Dec 2023 to Jun 2026
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
No commentary or risk-factor text for this company.
Earnings calls
4 calls · Nov 2025 to Aug 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2026 Q2Aug 6, 2026
- FY2026 Q1May 6, 2026
- FY2025 Q4Mar 11, 2026
- FY2025 Q3Nov 10, 2025
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 17, 2026) and refreshed every few hours.